NORTH BILLERICA, MA--(Marketwire - August 17, 2009) -
HydroCision Inc. (www.hydrocision.com
announced today that revenue for the second quarter of 2009 increased by
43% over the same fiscal quarter 2008. Trailing quarter product sales
increased by 21%, indicating accelerated momentum in the spine business and
a growing interest from physicians and hospitals in the company's products
and the medico-economic benefits to the healthcare system.
HydroCision has released multiple products for two spinal applications. One
application is for spinal fusion preparation and the other is for minimally
invasive discectomy. "Both platforms demonstrated strong year over year
growth in the second quarter," Doug Daniels CEO commented. "We are pleased
with the growth of our SpineJet franchise."
"The team at HydroCision has done an extraordinary job in keeping the
patient, and the physicians at the center of our business. By focusing our
sales team on continued physician education, and highlighting the positive
results from clinical studies we have seen significant top line and bottom
line growth. We are looking forward to continued revenue growth in the
third quarter of 2009 through further penetration of the company's core
products and two new product releases."
Lower back pain is the second most common neurological ailment in the
United States and is the most common cause of job-related disability and a
leading contributor to missed work and reduced work productivity.(1,2)
Approximately 80 percent of all Americans experience back and/or leg pain
at some point in their lives, and as many as 50 percent of working-age
adults cope with back and/or leg pain annually.(3)
1. National Institute of Neurological Disorders and Stroke. Low back pain
fact sheet. available from:
2. Hemp P. Presenteeism: At Work but Out of It Harv. Business Review 2004;
3. Valifors B. Acute, Subacute and Chronic Low Back Pain; Clinical
Symptoms, Absenteeism and Working Environment, Scan J. Rehab med
Supplement 1985; 11: 1-96
HydroCision Inc. (www.hydrocision.com) is a leading designer, developer and
distributor of fluidjet surgical tools. This new proprietary fluidjet
technology is the basis of a new surgical modality, "HydroSurgery," which
has positive clinical experience, novel features and versatility.
HydroCision has developed a broad range of fluidjet products to meet the
clinical and economic needs of multiple specialties.